USA Genetic Engineering Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Genetic engineering is a technology that uses biotechnology to directly manipulate the genome of an organism to change the genetic material of cells.

    The most prominent advantage of genetic engineering is that it breaks the boundaries between species that are difficult to break through conventional breeding techniques, and can reorganize and transfer genetic information between prokaryotes and eukaryotes, between animals and plants, and even between humans and other organisms.

    The development of genetic engineering is driven by the development of the pharmaceutical industry, advances in genetic research, and strong support from related policies. In addition, the beneficial effects of genetic engineering on humans and the demand for better performance products have also promoted the development of genetic engineering to a certain extent.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Genetic Engineering market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Genetic Engineering market. Detailed analysis of key players, along with key growth strategies adopted by Genetic Engineering industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Sangamo Therapeutics, Inc (US)

    • Horizon Discovery Group Plc (UK)

    • Genscript Biotech Corporation (US)

    • Transposagen Biopharmaceuticals Inc (US)

    • Lonza Group Ltd (Germany)

    • Merck KGaA (US)

    • Transposagen Biopharmaceuticals, Inc (Switzerland)

    • Origene Technologies Inc (US)

    • Thermo Fisher Scientific Inc Inc (US)

    • Others (US)

    • New England Biolabs(US)

    • Sangamo Therapeutics Inc (US)

    By Type:

    • Artificial Selection

    • Cloning

    • Gene Splicing

    • OriGene Technologies, Inc

    By End-User:

    • Research Institution

    • Academic Institution

    • Pharmaceutical Industry

    • OriGene Technologies, Inc

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Genetic Engineering Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Genetic Engineering Market Size and Growth Rate of Artificial Selection from 2016 to 2027

      • 1.3.2 USA Genetic Engineering Market Size and Growth Rate of Cloning from 2016 to 2027

      • 1.3.3 USA Genetic Engineering Market Size and Growth Rate of Gene Splicing from 2016 to 2027

      • 1.3.4 USA Genetic Engineering Market Size and Growth Rate of OriGene Technologies, Inc from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Genetic Engineering Market Size and Growth Rate of Research Institution from 2016 to 2027

      • 1.4.2 USA Genetic Engineering Market Size and Growth Rate of Academic Institution from 2016 to 2027

      • 1.4.3 USA Genetic Engineering Market Size and Growth Rate of Pharmaceutical Industry from 2016 to 2027

      • 1.4.4 USA Genetic Engineering Market Size and Growth Rate of OriGene Technologies, Inc from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Genetic Engineering Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Genetic Engineering Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Genetic Engineering Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Genetic Engineering Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Genetic Engineering Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Genetic Engineering by Major Types

      • 3.4.1 Market Size and Growth Rate of Artificial Selection

      • 3.4.2 Market Size and Growth Rate of Cloning

      • 3.4.3 Market Size and Growth Rate of Gene Splicing

      • 3.4.4 Market Size and Growth Rate of OriGene Technologies, Inc

    4 Segmentation of Genetic Engineering Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Genetic Engineering by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Genetic Engineering in Research Institution

      • 4.4.2 Market Size and Growth Rate of Genetic Engineering in Academic Institution

      • 4.4.3 Market Size and Growth Rate of Genetic Engineering in Pharmaceutical Industry

      • 4.4.4 Market Size and Growth Rate of Genetic Engineering in OriGene Technologies, Inc

    5 Market Analysis by Regions

    • 5.1 USA Genetic Engineering Production Analysis by Regions

    • 5.2 USA Genetic Engineering Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Genetic Engineering Landscape Analysis

    • 6.1 West USA Genetic Engineering Landscape Analysis by Major Types

    • 6.2 West USA Genetic Engineering Landscape Analysis by Major End-Users

    7 South USA Genetic Engineering Landscape Analysis

    • 7.1 South USA Genetic Engineering Landscape Analysis by Major Types

    • 7.2 South USA Genetic Engineering Landscape Analysis by Major End-Users

    8 Middle West USA Genetic Engineering Landscape Analysis

    • 8.1 Middle West USA Genetic Engineering Landscape Analysis by Major Types

    • 8.2 Middle West USA Genetic Engineering Landscape Analysis by Major End-Users

    9 Northeast USA Genetic Engineering Landscape Analysis

    • 9.1 Northeast USA Genetic Engineering Landscape Analysis by Major Types

    • 9.2 Northeast USA Genetic Engineering Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Sangamo Therapeutics, Inc (US)

        • 10.1.1 Sangamo Therapeutics, Inc (US) Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Horizon Discovery Group Plc (UK)

        • 10.2.1 Horizon Discovery Group Plc (UK) Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Genscript Biotech Corporation (US)

        • 10.3.1 Genscript Biotech Corporation (US) Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Transposagen Biopharmaceuticals Inc (US)

        • 10.4.1 Transposagen Biopharmaceuticals Inc (US) Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Lonza Group Ltd (Germany)

        • 10.5.1 Lonza Group Ltd (Germany) Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Merck KGaA (US)

        • 10.6.1 Merck KGaA (US) Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Transposagen Biopharmaceuticals, Inc (Switzerland)

        • 10.7.1 Transposagen Biopharmaceuticals, Inc (Switzerland) Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Origene Technologies Inc (US)

        • 10.8.1 Origene Technologies Inc (US) Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Thermo Fisher Scientific Inc Inc (US)

        • 10.9.1 Thermo Fisher Scientific Inc Inc (US) Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Others (US)

        • 10.10.1 Others (US) Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 New England Biolabs(US)

        • 10.11.1 New England Biolabs(US) Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Sangamo Therapeutics Inc (US)

        • 10.12.1 Sangamo Therapeutics Inc (US) Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Genetic Engineering Market Size and Growth Rate of Artificial Selection from 2016 to 2027

    • Figure USA Genetic Engineering Market Size and Growth Rate of Cloning from 2016 to 2027

    • Figure USA Genetic Engineering Market Size and Growth Rate of Gene Splicing from 2016 to 2027

    • Figure USA Genetic Engineering Market Size and Growth Rate of OriGene Technologies, Inc from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Genetic Engineering Market Size and Growth Rate of Research Institution from 2016 to 2027

    • Figure USA Genetic Engineering Market Size and Growth Rate of Academic Institution from 2016 to 2027

    • Figure USA Genetic Engineering Market Size and Growth Rate of Pharmaceutical Industry from 2016 to 2027

    • Figure USA Genetic Engineering Market Size and Growth Rate of OriGene Technologies, Inc from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Genetic Engineering Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Genetic Engineering Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Genetic Engineering Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Genetic Engineering Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Genetic Engineering Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Genetic Engineering

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Genetic Engineering by Different Types from 2016 to 2027

    • Table Consumption Share of Genetic Engineering by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Artificial Selection

    • Figure Market Size and Growth Rate of Cloning

    • Figure Market Size and Growth Rate of Gene Splicing

    • Figure Market Size and Growth Rate of OriGene Technologies, Inc

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Genetic Engineering by Different End-Users from 2016 to 2027

    • Table Consumption Share of Genetic Engineering by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Research Institution

    • Figure Market Size and Growth Rate of Academic Institution

    • Figure Market Size and Growth Rate of Pharmaceutical Industry

    • Figure Market Size and Growth Rate of OriGene Technologies, Inc

    • Table USA Genetic Engineering Production by Regions

    • Table USA Genetic Engineering Production Share by Regions

    • Figure USA Genetic Engineering Production Share by Regions in 2016

    • Figure USA Genetic Engineering Production Share by Regions in 2021

    • Figure USA Genetic Engineering Production Share by Regions in 2027

    • Table USA Genetic Engineering Consumption by Regions

    • Table USA Genetic Engineering Consumption Share by Regions

    • Figure USA Genetic Engineering Consumption Share by Regions in 2016

    • Figure USA Genetic Engineering Consumption Share by Regions in 2021

    • Figure USA Genetic Engineering Consumption Share by Regions in 2027

    • Table West USA Genetic Engineering Consumption by Types from 2016 to 2027

    • Table West USA Genetic Engineering Consumption Share by Types from 2016 to 2027

    • Figure West USA Genetic Engineering Consumption Share by Types in 2016

    • Figure West USA Genetic Engineering Consumption Share by Types in 2021

    • Figure West USA Genetic Engineering Consumption Share by Types in 2027

    • Table West USA Genetic Engineering Consumption by End-Users from 2016 to 2027

    • Table West USA Genetic Engineering Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Genetic Engineering Consumption Share by End-Users in 2016

    • Figure West USA Genetic Engineering Consumption Share by End-Users in 2021

    • Figure West USA Genetic Engineering Consumption Share by End-Users in 2027

    • Table South USA Genetic Engineering Consumption by Types from 2016 to 2027

    • Table South USA Genetic Engineering Consumption Share by Types from 2016 to 2027

    • Figure South USA Genetic Engineering Consumption Share by Types in 2016

    • Figure South USA Genetic Engineering Consumption Share by Types in 2021

    • Figure South USA Genetic Engineering Consumption Share by Types in 2027

    • Table South USA Genetic Engineering Consumption by End-Users from 2016 to 2027

    • Table South USA Genetic Engineering Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Genetic Engineering Consumption Share by End-Users in 2016

    • Figure South USA Genetic Engineering Consumption Share by End-Users in 2021

    • Figure South USA Genetic Engineering Consumption Share by End-Users in 2027

    • Table Middle West USA Genetic Engineering Consumption by Types from 2016 to 2027

    • Table Middle West USA Genetic Engineering Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Genetic Engineering Consumption Share by Types in 2016

    • Figure Middle West USA Genetic Engineering Consumption Share by Types in 2021

    • Figure Middle West USA Genetic Engineering Consumption Share by Types in 2027

    • Table Middle West USA Genetic Engineering Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Genetic Engineering Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Genetic Engineering Consumption Share by End-Users in 2016

    • Figure Middle West USA Genetic Engineering Consumption Share by End-Users in 2021

    • Figure Middle West USA Genetic Engineering Consumption Share by End-Users in 2027

    • Table Northeast USA Genetic Engineering Consumption by Types from 2016 to 2027

    • Table Northeast USA Genetic Engineering Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Genetic Engineering Consumption Share by Types in 2016

    • Figure Northeast USA Genetic Engineering Consumption Share by Types in 2021

    • Figure Northeast USA Genetic Engineering Consumption Share by Types in 2027

    • Table Northeast USA Genetic Engineering Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Genetic Engineering Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Genetic Engineering Consumption Share by End-Users in 2016

    • Figure Northeast USA Genetic Engineering Consumption Share by End-Users in 2021

    • Figure Northeast USA Genetic Engineering Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Sangamo Therapeutics, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sangamo Therapeutics, Inc (US)

    • Figure Sales and Growth Rate Analysis of Sangamo Therapeutics, Inc (US)

    • Figure Revenue and Market Share Analysis of Sangamo Therapeutics, Inc (US)

    • Table Product and Service Introduction of Sangamo Therapeutics, Inc (US)

    • Table Company Profile and Development Status of Horizon Discovery Group Plc (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Horizon Discovery Group Plc (UK)

    • Figure Sales and Growth Rate Analysis of Horizon Discovery Group Plc (UK)

    • Figure Revenue and Market Share Analysis of Horizon Discovery Group Plc (UK)

    • Table Product and Service Introduction of Horizon Discovery Group Plc (UK)

    • Table Company Profile and Development Status of Genscript Biotech Corporation (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genscript Biotech Corporation (US)

    • Figure Sales and Growth Rate Analysis of Genscript Biotech Corporation (US)

    • Figure Revenue and Market Share Analysis of Genscript Biotech Corporation (US)

    • Table Product and Service Introduction of Genscript Biotech Corporation (US)

    • Table Company Profile and Development Status of Transposagen Biopharmaceuticals Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Transposagen Biopharmaceuticals Inc (US)

    • Figure Sales and Growth Rate Analysis of Transposagen Biopharmaceuticals Inc (US)

    • Figure Revenue and Market Share Analysis of Transposagen Biopharmaceuticals Inc (US)

    • Table Product and Service Introduction of Transposagen Biopharmaceuticals Inc (US)

    • Table Company Profile and Development Status of Lonza Group Ltd (Germany)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lonza Group Ltd (Germany)

    • Figure Sales and Growth Rate Analysis of Lonza Group Ltd (Germany)

    • Figure Revenue and Market Share Analysis of Lonza Group Ltd (Germany)

    • Table Product and Service Introduction of Lonza Group Ltd (Germany)

    • Table Company Profile and Development Status of Merck KGaA (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA (US)

    • Figure Sales and Growth Rate Analysis of Merck KGaA (US)

    • Figure Revenue and Market Share Analysis of Merck KGaA (US)

    • Table Product and Service Introduction of Merck KGaA (US)

    • Table Company Profile and Development Status of Transposagen Biopharmaceuticals, Inc (Switzerland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Transposagen Biopharmaceuticals, Inc (Switzerland)

    • Figure Sales and Growth Rate Analysis of Transposagen Biopharmaceuticals, Inc (Switzerland)

    • Figure Revenue and Market Share Analysis of Transposagen Biopharmaceuticals, Inc (Switzerland)

    • Table Product and Service Introduction of Transposagen Biopharmaceuticals, Inc (Switzerland)

    • Table Company Profile and Development Status of Origene Technologies Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Origene Technologies Inc (US)

    • Figure Sales and Growth Rate Analysis of Origene Technologies Inc (US)

    • Figure Revenue and Market Share Analysis of Origene Technologies Inc (US)

    • Table Product and Service Introduction of Origene Technologies Inc (US)

    • Table Company Profile and Development Status of Thermo Fisher Scientific Inc Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific Inc Inc (US)

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific Inc Inc (US)

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific Inc Inc (US)

    • Table Product and Service Introduction of Thermo Fisher Scientific Inc Inc (US)

    • Table Company Profile and Development Status of Others (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Others (US)

    • Figure Sales and Growth Rate Analysis of Others (US)

    • Figure Revenue and Market Share Analysis of Others (US)

    • Table Product and Service Introduction of Others (US)

    • Table Company Profile and Development Status of New England Biolabs(US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of New England Biolabs(US)

    • Figure Sales and Growth Rate Analysis of New England Biolabs(US)

    • Figure Revenue and Market Share Analysis of New England Biolabs(US)

    • Table Product and Service Introduction of New England Biolabs(US)

    • Table Company Profile and Development Status of Sangamo Therapeutics Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sangamo Therapeutics Inc (US)

    • Figure Sales and Growth Rate Analysis of Sangamo Therapeutics Inc (US)

    • Figure Revenue and Market Share Analysis of Sangamo Therapeutics Inc (US)

    • Table Product and Service Introduction of Sangamo Therapeutics Inc (US)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.